Skip to content
Medical Health Aged Care

ClaroNav Kolahi Inc. Announces EU MDR Certification for Navient Surgical Navigation System

ClaroNav Kolahi Inc. 2 mins read
TORONTO--BUSINESS WIRE--

ClaroNav Kolahi Inc. (CKI), a global developer and manufacturer of surgical navigation technologies, today announced that its Navient Surgical Navigation System has received certification under the European Union Medical Device Regulation, EU MDR.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007890668/en/

ClaroNav Kolahi Inc. Announces EU MDR Certification for Navient Surgical Navigation System

ClaroNav Kolahi Inc. Announces EU MDR Certification for Navient Surgical Navigation System

The certification covers the Navient Image Guided Navigation System and its reusable surgical instruments, allowing CKI to continue offering Navient throughout the European Union under the EU MDR regulatory framework.

“EU MDR certification is an important milestone for CKI and demonstrates our continued commitment to meeting the highest standards for safety, quality, and regulatory compliance,” said Ahmad Kolahi, CEO of CKI.

Navient was previously certified under EU MDD and has received regulatory approvals including US FDA, Health Canada, China NMPA, and Japan PMDA. Today, Navient is installed in more than 70 countries, with an installed base of more than 250 systems worldwide.

For spine surgery, CKI has expanded the Navient platform with FluoroGuide 2D and its first in market CT/MRI to Fluoro Registration technology, integrating both preoperative CT and MRI with intraoperative 2D fluoroscopy for advanced 3D navigation.

“Access to advanced spine navigation remains limited worldwide, in part due to the high cost and complexity of intraoperative 3D imaging required by many navigation platforms,” said Ahmad Kolahi, CEO of CKI. “Navient’s CT/MRI to Fluoro Registration is designed to remove this barrier and make navigation more accessible and affordable. It enables hospitals and ambulatory surgery centers, ASCs, to use the conventional 2D C arm they already own while gaining access to advanced 3D navigation, reducing equipment cost and workflow complexity and, more importantly, helping reduce radiation exposure for both patients and operating room staff.”

About Navient

Navient is CKI’s surgical navigation platform for spine, cranial, ENT, and biopsy procedures. Designed around the principles: Intuitive. Precise. Portable., Navient combines advanced optical tracking, imaging integration, registration technologies, and AI assisted surgical planning in a compact and portable platform, making advanced navigation practical and accessible for a broader range of hospitals, ASCs, and outpatient surgical facilities.

About ClaroNav Kolahi Inc.(CKI)

CKI is a Toronto based medical technology company specializing in advanced surgical navigation systems. By combining intelligent, AI powered software with precision engineered hardware, CKI develops next generation solutions that empower surgeons with smarter tools and greater precision to enhance clinical confidence and improve patient outcomes.


Contact details:

ClaroNav Kolahi Inc.
Website https://medical.claronav.com/
Email: [email protected]

Media

More from this category

  • Indigenous, Medical Health Aged Care
  • 13/11/2026
  • 01:05
Cancer Australia

Grants open to support children and young people affected by cancer

Key Facts: The 2027 Supporting People with Cancer grant program is now open, offering at least $480,000 in funding (£50,000–$120,000 per recipient) for community-led projects improving outcomes for children and young people affected by cancer. This round prioritises projects focused on children, adolescents, and young adults with cancer and their families, in line with Cancer Australia's Childhood and Adolescent and Young Adult Cancer Roadmap. Funding targets communities that experience poorer cancer outcomes, including Aboriginal and Torres Strait Islander peoples, culturally and linguistically diverse groups, those in lower socioeconomic groups, and people in rural and remote areas. Applications are open to…

  • Medical Health Aged Care
  • 12/11/2026
  • 23:53
Takeda Pharmaceutical Company Limited

Takeda Launches ORZEYFUL(TM) (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States

Adults Living with NT1 Can Now be Prescribed ORZEYFUL, a New First-in-Class Orexin Medicine that Treats the Disease Holistically ORZEYFUL has the Potential to…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 12/11/2026
  • 15:40
Medibank Group

Medibank and Pharmacycle make it easier to recycle medicine blister packs

This National Recycling Week, Medibank is partnering with Pharmacycle to help Australians give their empty medicine blister packs a second life. Empty medicine blister…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.